LeMaitre Vascular
LMAT
288 hedge funds and large institutions have $1.77B invested in LeMaitre Vascular in 2025 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 104 increasing their positions, 123 reducing their positions, and 44 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.56% less ownership
Funds ownership: 94.27% → 93.71% (-0.56%)
6% less funds holding
Funds holding: 307 → 288 (-19)
9% less capital invested
Capital invested by funds: $1.95B → $1.77B (-$179M)
15% less repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 123
26% less call options, than puts
Call options by funds: $25K | Put options by funds: $34K
39% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 44
Top Buyers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$32.8M |
| 2 |
Millennium Management
New York
|
+$10.7M |
| 3 |
Rockefeller Capital Management
New York
|
+$8.71M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$8.02M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$6.75M |
Top Sellers
LMAT Hedge Fund Activity: Q1 2025 in Review
288 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q1 2025, worth a combined $1.77B — down 9.2% from $1.95B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of LMAT and 27 opened new positions — a net loss of 17 holders — while 123 trimmed existing stakes and 104 added.
The largest buyer was First Trust Advisors, adding an estimated $32.8M. The largest seller was BlackRock, cutting an estimated $30.1M.
- 288 institutional investors held LeMaitre Vascular (LMAT) as of Q1 2025, down from 307 in Q4 2024.
- Funds reported $1.77B of LeMaitre Vascular stock for Q1 2025, down 9.2% quarter-over-quarter.
- 27 funds opened new LeMaitre Vascular positions in Q1 2025 and 44 closed out, a net change of -17 holders.
- The largest LeMaitre Vascular buyer in Q1 2025 was First Trust Advisors, an estimated $32.8M added.
- The largest LeMaitre Vascular seller in Q1 2025 was BlackRock, an estimated $30.1M sold.
Based on aggregated 13F filings for Q1 2025.